Cart
sales@molnova.com
IL-17A inhibitor 1
CAS No. 2452464-73-0
IL-17A inhibitor 1( —— )
Catalog No. M28693 CAS No. 2452464-73-0
IL-17A inhibitor 1 (example 24) is an inhibitor of IL-17A.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 1764 | Get Quote |
|
| 10MG | 2713 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameIL-17A inhibitor 1
-
NoteResearch use only, not for human use.
-
Brief DescriptionIL-17A inhibitor 1 (example 24) is an inhibitor of IL-17A.
-
DescriptionIL-17A inhibitor 1 (example 24) is an inhibitor of IL-17A.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetIL Receptor
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2452464-73-0
-
Formula Weight586.524
-
Molecular FormulaC24H27F5N8O4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 250 mg/mL (426.25 mM)
-
SMILESCOC[C@@H](N1C[C@H](NC1=O)C(F)(F)F)c1cnn2cc(nc2c1)[C@@H](NC(=O)c1nonc1C)C1CCC(F)(F)CC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Bao B, et al. Monoindole alkaloids from a marine sponge Spongosorites sp. Mar Drugs. 2007 Jun 25;5(2):31-9.
molnova catalog
related products
-
Enokizumab
Enokizumab?(MEDI-528) is a monoclonal antibody against interleukin IL-9. Enokizumab can be used to study asthma.
-
Pascolizumab
Pascolizumab (SB-240683) is a humanized monoclonal antibody targeting IL-4, exhibiting asthmatic effects and useful for studying allergic rhinitis.
-
Secukinumab B
Secukinumab is a fully humanized monoclonal anti-IL-17A antibody and the first in its class to be approved by the US Food and Drug Administration for the treatment of moderate to severe plaque psoriasis.
